ImmunoPrecise Antibodies Ltd. - Common Stock (NQ:IPA)

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.

Gold Moves Higher; Campbell Soup Earnings Top Expectations

December 06, 2023

Via Benzinga

Topics Stocks

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

Earnings Outlook For ImmunoPrecise Antibodies

September 13, 2023

Via Benzinga

Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Today

December 06, 2023

ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at

Via Benzinga

Crude Oil Down 4%; Pharvaris Shares Spike Higher

December 06, 2023

U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...

Via Benzinga

Topics Stocks

US Stocks Higher; Private Payrolls Rise By 103,000 In November

December 06, 2023

U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...

Via Benzinga

Topics Stocks

Why Is Carbon Revolution (CREV) Stock Down Today?

December 06, 2023

Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call.

Via InvestorPlace

Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?

December 06, 2023

ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA.

Via InvestorPlace

Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

December 06, 2023

Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.

Via Benzinga

ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14

December 06, 2023

ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

December 06, 2023

It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning!

Via InvestorPlace

IPA Announces Pricing of $1.1 Million Public Offering of Common Shares

December 06, 2023

IPA Announces Proposed Public Offering of Common Shares

December 05, 2023

ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call

November 27, 2023

ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery

November 22, 2023

ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery

November 20, 2023

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand®, has launched an advanced Retrieval Augmented...

Via Benzinga

BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research

November 13, 2023

EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval

November 13, 2023

ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary BioStrand has published a preprint of its white paper titled "New Paradigm for Biological Sequence Retrieval Inspired by Natural

Via Benzinga

IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™

October 25, 2023

IPA Provides Update on Growth Strategy and Recent Share Price Movement

October 23, 2023

Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data

October 20, 2023

Overcoming The Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data

October 19, 2023

Biotechnology research involves a vast amount of complex information that spans different dimensions, such as the functions of proteins, the 3D structures of molecules and the genetic information...

Via Benzinga

How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research

October 13, 2023

The introduction of artificial intelligence (AI) in healthcare has revolutionized the field, allowing for a more personalized approach to patient care. AI algorithms have the ability to process and...

How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research

October 12, 2023

Via Benzinga

Topics Artificial Intelligence

ImmunoPrecise Antibodies Announces CFO Transition

September 19, 2023

IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024

September 14, 2023

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023

September 08, 2023

IPA Announces Board Refreshment

September 05, 2023

IPA Responds to 13D Filing

August 09, 2023